IPIX (Innovation Pharmaceuticals) Total Operating Expense: $2.36 Mil (TTM As of Sep. 2023)


What is Innovation Pharmaceuticals Total Operating Expense?

Innovation Pharmaceuticals IPIX Total Operating Expense is $2.36 Mil as of Sep. 2023.

Innovation Pharmaceuticals's Total Operating Expense for the three months ended in Sep. 2023 was $0.80 Mil. Innovation Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was $2.36 Mil.

Innovation Pharmaceuticals Total Operating Expense Related Terms

Innovation Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Total Operating Expense Chart

Innovation Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.45 5.06 9.02 6.78 2.94

Innovation Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 0.33 0.64 0.58 0.80

Innovation Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $2.36 Mil mean?
Innovation Pharmaceuticals (IPIX) has a Total Operating Expense of $2.36 Mil as of Sep. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Total Operating Expense too high?
Innovation Pharmaceuticals' current Total Operating Expense is $2.36 Mil.
How does Innovation Pharmaceuticals' Total Operating Expense compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Total Operating Expense of $2.36 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Innovation Pharmaceuticals and its competitors. Innovation Pharmaceuticals's current Total Operating Expense is $2.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Total Operating Expense of $2.36 Mil. The current Total Operating Expense is $2.36 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Total Operating Expense is $2.36 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.